What Vanda Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 6 |
| Total trades | 0 | 20 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,411,701 |
| Disposed | 0 | 370,178 |
| Net activity | +0 | +1,041,523 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mitchell Stephen Ray | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 112,846 |
| Honore Tage | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 135,069 |
| Chrousos Phaedra | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 164,950 |
| Dugan Richard W | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 219,054 |
| Ward Anne Sempowski | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 160,667 |
| Duncan Charles Cliff | Director | Jun 04 | Grant / award · A | +41,600 | — | — | 98,701 |
| McGuire Daniel Patrick | SVP, GC and Secretary | Jun 04 | Grant / award · A | +80,000 | — | — | 109,982 |
| Mitchell Stephen Ray | Director | May 18 | Gift · G | −25,836 | — | — | 71,246 |
| Duncan Charles Cliff | Director | Apr 22 | Grant / award · A | +57,101 | — | — | 57,101 |
| Williams Timothy | SVP & General Counsel | Mar 02 | Sale for tax withholding · S | −42,434 | $8.27 | −$351K | 377,450 |
| Polymeropoulos Mihael Hristos | President and CEO | Mar 02 | Sale for tax withholding · S | −156,235 | $8.17 | −$1.28M | 2,704,496 |
| Wijkstrom Joakim | SVP, Chief Marketing Officer | Mar 02 | Sale for tax withholding · S | −30,800 | $8.27 | −$255K | 333,469 |
| Birznieks Gunther | SVP, Business Development | Mar 02 | Sale for tax withholding · S | −42,431 | $8.27 | −$351K | 494,197 |
| Moran Kevin Patrick | SVP, CFO & Treasurer | Mar 02 | Sale for tax withholding · S | −42,442 | $8.27 | −$351K | 411,380 |
| Honore Tage | Director | Feb 23 | Open-market sale · S | −30,000 | $8.03 | −$241K | 93,469 |
| Williams Timothy | SVP & General Counsel | Feb 18 | Grant / award · A | +125,000 | — | — | 419,884 |
| Polymeropoulos Mihael Hristos | President and CEO | Feb 18 | Grant / award · A | +525,000 | — | — | 2,860,731 |
| Wijkstrom Joakim | SVP, Chief Marketing Officer | Feb 18 | Grant / award · A | +125,000 | — | — | 364,269 |
| Birznieks Gunther | SVP, Business Development | Feb 18 | Grant / award · A | +125,000 | — | — | 536,628 |
| Moran Kevin Patrick | SVP, CFO & Treasurer | Feb 18 | Grant / award · A | +125,000 | — | — | 453,822 |
Loading...
